News Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-12-09 pm EST			5-day change	1st Jan Change
83.28 ^USD	-1.23%		-1.69%	+12.49%

Dec. 08	Leerink Partners Adjusts Edwards Lifesciences PT to $87 From $88, Maintains Market Perform Rating	MT
Dec. 05	Sector Update: Health Care Stocks Lower Late Afternoon	MT

Leerink Partners Adjusts Edwards Lifesciences PT to $87 From $88, Maintains Market Perform Rating	Dec. 08	MT
Sector Update: Health Care Stocks Lower Late Afternoon	Dec. 05	MT
Edwards Lifesciences : EW 2025 IC FINAL	Dec. 05	PU
Bernstein Adjusts Edwards Lifesciences Price Target to $95 From $90, Maintains Market Perform Rating	Dec. 05	MT
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says	Dec. 05	MT
Raymond James Adjusts PT on Edwards Lifesciences to $100 From $96, Maintains Outperform Rating	Dec. 05	MT
UBS Adjusts Price Target on Edwards Lifesciences to $92 From $90, Maintains Neutral Rating	Dec. 05	MT
Truist Securities Adjusts PT on Edwards Lifesciences to $92 From $90, Maintains Hold Rating	Dec. 05	MT
RBC Raises Price Target on Edwards Lifesciences to $100 From $95, Keeps Outperform Rating	Dec. 05	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $100 From $95, Maintains Buy Rating	Dec. 05	MT
BTIG Adjusts Price Target on Edwards Lifesciences to $103 From $100, Maintains Buy Rating	Dec. 05	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $96 From $95, Maintains Overweight Rating	Dec. 05	MT
Barclays Adjusts Price Target on Edwards Lifesciences to $103 From $99, Maintains Overweight Rating	Dec. 05	MT
Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $89 From $84, Maintains Hold Rating	Dec. 05	MT
Baird Adjusts Price Target on Edwards Lifesciences to $88 From $83, Maintains Neutral Rating	Dec. 05	MT
Edwards Lifesciences : 2025 Investor Conference	Dec. 04	PU
Edwards Lifesciences Reiterates 2025 Guidance; 2026 Forecast Issued	Dec. 04	MT
Edwards Lifesciences reaffirms strategy for sustainable, differentiated growth at annual investor conference	Dec. 04	RE
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference	Dec. 04	BU
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	Nov. 30	PR
Defining Claim Terms By Implication: Lexicography Lessons From Aortic Innovations LLC v. Edwards Lifesciences Corporation	Nov. 20	AQ
Medtronic raises annual sales growth forecast on heart devices demand	Nov. 18	RE
Royal Philips Introduces DeviceGuide	Nov. 17	CI
Argus Research Adjusts Edwards Lifesciences Price Target to $105 From $90, Maintains Buy Rating	Nov. 13	MT
Edwards Lifesciences Insider Sold Shares Worth $1,080,093, According to a Recent SEC Filing	Nov. 11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT